Archives of Obesity and Metabolism (비만대사연구학술지)

The Study of Obesity and Metabolic Syndrome, KAFM (대한가정의학회 비만대사증후군연구회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Secondary Obesity

이차성 비만의 진단

  • Kim, Bo-Yeon (Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital)
  • 김보연 (순천향대학교 부속 부천병원 내분비내과)
  • Received : 2022.10.13
  • Accepted : 2022.11.16
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

While the rising epidemic of obesity is primarily attributed to a sedentary lifestyle, poor dietary habits, and the aging of the population, secondary causes of obesity generally go undetected and untreated. These include endocrinological disorders, such as Cushing's syndrome, polycystic ovary syndrome, hypothalamic obesity, hypogonadism, and hypothyroidism, as well as genetic, syndromic, and drug-related obesity. We present an overview of the major disorders associated with obesity, highlighting the pathophysiologic mechanisms and discussing the diagnostic and treatment strategies that are most helpful to practicing physicians in recognizing and treating these generally under-detected and undertreated disorders.

Keywords

Acknowledgement

논문 검토와 수정을 해주신 리서치팩토리에게 감사드립니다.

References

  1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997;337:396-407. https://doi.org/10.1056/NEJM199708073370606
  2. Reinehr T, Hinney A, de Sousa G, Austrup F, Hebebrand J, Andler W. Definable somatic disorders in overweight children and adolescents. J Pediatr 2007;150:618-22, 622.e1-5. https://doi.org/10.1016/j.jpeds.2007.01.042
  3. Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea. J Obes Metab Syndr 2021;30:81-92. https://doi.org/10.7570/jomes21022
  4. Chiumello G, Manzoni P, Beccaria L, Simone P. Secondary obesity. Nutr Res 1993;13(Suppl 1):S109-16. https://doi.org/10.1016/S0271-5317(05)80288-X
  5. Allen G, Safranek S. FPIN's clinical inquiries. Secondary causes of obesity. Am Fam Physician 2011;83:972-3.
  6. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab 2016;20:554-7. https://doi.org/10.4103/2230-8210.183454
  7. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab 2010;95:3614-7. https://doi.org/10.1210/jc.2010-1245
  8. Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803. https://doi.org/10.1016/S0140-6736(04)15696-1
  9. Almandoz JP, Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am 2012;96:203-21. https://doi.org/10.1016/j.mcna.2012.01.005
  10. Persani L. Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 2012;97:3068-78. https://doi.org/10.1210/jc.2012-1616
  11. Persani L, Bonomi M, Radin R, Beck-Peccoz P. Diagnostic and therapeutic challenges of acquired thyrotropic deficiency. Ann Endocrinol (Paris) 2012;73:138-40. https://doi.org/10.1016/j.ando.2012.04.004
  12. Loriaux DL. Diagnosis and differential diagnosis of Cushing's syndrome. N Engl J Med 2017;376:1451-9. https://doi.org/10.1056/NEJMra1505550
  13. Fukuhara D, Takiura T, Keino H, Okada AA, Yan K. Iatrogenic Cushing's syndrome due to topical ocular glucocorticoid treatment. Pediatrics 2017;139:e20161233. https://doi.org/10.1542/peds.2016-1233
  14. Scutelnicu A, Panaitescu AM, Ciobanu AM, et al. Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy. Acta Endocrinol (Buchar) 2020;16:511-7. https://doi.org/10.4183/aeb.2020.511
  15. Joshi RR, Maresh A. Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction- case series and literature review. Int J Pediatr Otorhinolaryngol 2018;105:123-6. https://doi.org/10.1016/j.ijporl.2017.11.007
  16. Hochberg I, Hochberg Z. Hypothalamic obesity. Endocr Dev 2010;17:185-96. https://doi.org/10.1159/000262539
  17. Muller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 2016;23:81-9. https://doi.org/10.1097/MED.0000000000000214
  18. van Santen SS, Wolf P, Kremenevski N, et al. Bariatric surgery for hypothalamic obesity in craniopharyngioma patients: a retrospective, matched case-control study. J Clin Endocrinol Metab 2021;106:e4734-45.
  19. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999;23:260-71. https://doi.org/10.1038/sj.ijo.0800807
  20. Gasco V, Prodam F, Grottoli S, et al. GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses. Eur J Endocrinol 2013;168:R55-66. https://doi.org/10.1530/EJE-12-0563
  21. Lubrano C, Tenuta M, Costantini D, et al. Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study. Endocrine 2015;49:503-11. https://doi.org/10.1007/s12020-015-0530-0
  22. Diez JJ, Sangiao-Alvarellos S, Cordido F. Treatment with growth hormone for adults with growth hormone deficiency syndrome: benefits and risks. Int J Mol Sci 2018;19:893. https://doi.org/10.3390/ijms19030893
  23. Boguszewski CL. Update on GH therapy in adults. F1000Res 2017;6:2017. https://doi.org/10.12688/f1000research.12057.1
  24. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8. https://doi.org/10.1038/43185
  25. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004;101:4531-6. https://doi.org/10.1073/pnas.0308767101
  26. Gregoric N, Groselj U, Bratina N, et al. Two cases with an early presented proopiomelanocortin deficiency- a long-term follow-up and systematic literature review. Front Endocrinol (Lausanne) 2021;12:689387. https://doi.org/10.3389/fendo.2021.689387
  27. Aykut A, Ozen S, Goksen D, et al. Melanocortin 4 receptor (MC4R) gene variants in children and adolescents having familial early-onset obesity: genetic and clinical characteristics. Eur J Pediatr 2020;179:1445-52. https://doi.org/10.1007/s00431-020-03630-7
  28. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004;15:12-20. https://doi.org/10.1016/j.tem.2003.11.003
  29. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med 1981;304:325-9. https://doi.org/10.1056/NEJM198102053040604
  30. Ledbetter DH, Mascarello JT, Riccardi VM, Harper VD, Airhart SD, Strobel RJ. Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases. Am J Hum Genet 1982;34:278-85.
  31. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 2010;375:1737-48. https://doi.org/10.1016/S0140-6736(10)60171-7
  32. Stipancic G, Sepec MP. Secondary causes of obesity in children and adolescents. Central Eur J Paed 2018;14:1-11. https://doi.org/10.5457/p2005-114.193
  33. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96. https://doi.org/10.1176/ajp.156.11.1686
  34. Lazzaroni E, Ben Nasr M, Loretelli C, et al. Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacol Res 2021;171:105782. https://doi.org/10.1016/j.phrs.2021.105782
  35. Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 2010;303:1410-8. https://doi.org/10.1001/jama.2010.405
  36. Rosenthal NE, Genhart M, Jacobsen FM, Skwerer RG, Wehr TA. Disturbances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci 1987;499:216-30.
  37. Aguera Z, Lozano-Madrid M, Mallorqui-Bague N, Jimenez-Murcia S, Menchon JM, Fernandez-Aranda F. A review of binge eating disorder and obesity. Neuropsychiatr 2021;35:57-67. https://doi.org/10.1007/s40211-020-00346-w
  38. van der Valk ES, van den Akker ELT, Savas M, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev 2019;20:795-804. https://doi.org/10.1111/obr.12836